Assessment of Cardiac Sparing in Fetal Hypoxia
Doppler Echocardiography Assessment of Cardiac Sparing Effect in Fetal Hypoxia
1 other identifier
interventional
210
1 country
1
Brief Summary
The fetal heart plays a central role in the adaptive mechanisms for hypoxemia and placental insufficiency. Longitudinal data on the hemodynamic sequence of the natural history of fetal growth restriction show that the umbilical artery and middle cerebral artery are the first variables to become abnormal . These arterial Doppler abnormalities are followed by abnormalities in the right cardiac diastolic indices, followed by the right cardiac systolic indices, and finally by both left diastolic and systolic cardiac indices . Preserving the left systolic function as the last variable to become abnormal ensures an adequate left ventricular output , which supplies the cerebral and coronary circulations.This defence is contingent on the fetal cardiovascular system, which in late gestation adopts strategies to decrease oxygen consumption and redistribute the cardiac output away from peripheral vascular beds and towards essential circulations, such as those perfusing the brain. Adding cardiac Doppler may improve management of the IUGR fetus(intrauterine growth retardation), Doppler ultrasound is valuable in defining the degree of cardiovascular compromise in at-risk pregnancies. The severity of fetal blood flow redistribution shows the degree of fetal adaptation and provides information on how long the pregnancy can be continued safely. The aime of the study is assessment of cardiac output redistribution in fetal hypoxia by estimating relative right to left side cardiac output wich reflect cardiac sparing in (IUGR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2017
CompletedFirst Posted
Study publicly available on registry
May 10, 2017
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedNovember 30, 2022
November 1, 2022
4.8 years
May 7, 2017
November 26, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The relative cardiac output ratio (ratio between right side cardiac outputs to left side) cardiac output) at 32-34 weeks.
1 month
Secondary Outcomes (6)
The relative cardiac output ratio at 34-36 weeks.
1 month
The pulsatility index in the umbilical artery and middle cerebral artery at 32-34 weeks
1 month
The pulsatility index in the umbilical artery and middle cerebral artery at 34-36 weeks
1 month
Middle cerebral artery pulsatility index to umbilical artery pulsatility index ratio
15 minutes
Time of delivery (weeks)
7 weeks
- +1 more secondary outcomes
Study Arms (2)
Normal pregnant women at 32-34 weeks group
OTHERIntrauterine growth restriction at 32-34 weeks group
OTHERInterventions
ultrasound assessment of gestational age, amniotic fluid index, and fetal weight
Umbilical artery and Middle cerebral artery Doppler blood flow assesment
The cardiac output (ratio between right side cardiac outputs to left side cardiac output) was calculated
Eligibility Criteria
You may qualify if:
- Women aged 20-35 years.
- Women with BMI from 20-30 kg/m2.
- Pregnant women in singleton fetuses from 32 to 34 weeks gestation.
- Women with late fetal growth restriction fetuses. It refers to an estimated fetal weight or abdominal circumference \<10th centile. Those women had increased the resistant index (RI) in umbilical arteries above the 95th percentile at the time of recruitment (case group).
- Normal pregnant women (control group).
You may not qualify if:
- Women with estimated fetal weight below the 5th or 3rd percentile.
- Women with premature pre-labor rupture of membranes.
- Women with antepartum hemorrhage
- Women with fetal congenital anomalies.
- Women with absent or reversed diastolic flow in the umbilical artery at the time of recruitment.
- Women with preeclampsia or on anti-coagulant thereby.
- Women who refused to participate in our study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Advanced Fetal Cair Unit - Assiut University
Asyut, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 7, 2017
First Posted
May 10, 2017
Study Start
August 1, 2017
Primary Completion
May 1, 2022
Study Completion
September 1, 2022
Last Updated
November 30, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will share